iBio IBIO
NASDAQ IBIO
$1.19 +0.02 (+1.71%)
As of: Sep 30, 2026 · 9:31 AM EDT

iBio (IBIO) Operating Expenses (2010 - 2026)

Updated

iBio's Operating Expenses was $11.38 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 110.8% from $5.4 million a year earlier and up 36.0% from the prior quarter.

Analysis

iBio (IBIO) Operating Expenses (2010 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Operating Expenses at iBio came in at $35.24 million, up 85.5% from FY2025.

  • Operating Expenses shows a five-year compound annual growth rate of 1.9% (FY2021 to FY2026).
  • In earlier fiscal years, Operating Expenses was $19 million in FY2025 (+12.7%), $16.86 million in FY2024 (-42.5%), $29.34 million in FY2023 (-7.1%) and $31.58 million in FY2022 (-1.4%).
  • The fiscal Q4 2026 figure marks the highest quarterly Operating Expenses in data going back to fiscal Q1 2011.
  • Compared with a year earlier, Operating Expenses has increased for seven straight quarters, with growth averaging 50.2% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was fiscal Q4 2026 (growth of 110.8%); the worst was fiscal Q2 2024 (a decline of 57.5%).
  • Per Business Quant data, IBIO's Operating Expenses in the three fiscal quarters before Q4 2026 was $8.37 million (Q3 2026), $9.45 million (Q2 2026) and $6.05 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 iBio 121.75 Mn 121.75 Mn - 11.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.38 Mn
Mar 31, 2026 8.37 Mn
Dec 31, 2025 9.45 Mn
Sep 30, 2025 6.05 Mn
Jun 30, 2025 5.40 Mn
Mar 31, 2025 4.88 Mn
Dec 31, 2024 4.62 Mn
Sep 30, 2024 4.11 Mn
Jun 30, 2024 3.58 Mn
Mar 31, 2024 3.63 Mn
Dec 31, 2023 4.50 Mn
Sep 30, 2023 5.15 Mn
Jun 30, 2023 4.97 Mn
Mar 31, 2023 6.17 Mn
Dec 31, 2022 10.57 Mn
Sep 30, 2022 7.64 Mn
Jun 30, 2022 10.45 Mn
Mar 31, 2022 8.59 Mn
Dec 31, 2021 7.23 Mn
Sep 30, 2021 5.31 Mn
API Access

iBio Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEY